2.74
price up icon13.22%   0.32
 
loading
Precedente Chiudi:
$2.42
Aprire:
$2.55
Volume 24 ore:
7.26M
Relative Volume:
1.35
Capitalizzazione di mercato:
$254.07M
Reddito:
-
Utile/perdita netta:
$-69.31M
Rapporto P/E:
-2.1575
EPS:
-1.27
Flusso di cassa netto:
$-62.80M
1 W Prestazione:
+36.32%
1M Prestazione:
-71.95%
6M Prestazione:
-35.38%
1 anno Prestazione:
-37.87%
Intervallo 1D:
Value
$2.51
$2.82
Intervallo di 1 settimana:
Value
$1.77
$2.82
Portata 52W:
Value
$1.07
$11.46

Rezolute Inc Stock (RZLT) Company Profile

Name
Nome
Rezolute Inc
Name
Telefono
650-206-4507
Name
Indirizzo
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY
Name
Dipendente
71
Name
Cinguettio
Name
Prossima data di guadagno
2025-09-17
Name
Ultimi documenti SEC
Name
RZLT's Discussions on Twitter

Confronta RZLT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
RZLT
Rezolute Inc
2.74 224.40M 0 -69.31M -62.80M -1.27
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
462.99 116.51B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
783.71 82.52B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
400.69 52.67B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
849.95 52.08B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
177.42 37.70B 447.02M -1.18B -906.14M -6.1812

Rezolute Inc Stock (RZLT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-12-11 Downgrade Cantor Fitzgerald Overweight → Neutral
2025-12-11 Downgrade Craig Hallum Buy → Hold
2025-12-11 Downgrade Wedbush Outperform → Neutral
2024-11-05 Iniziato Wedbush Outperform
2024-08-27 Iniziato Guggenheim Buy
2024-07-17 Iniziato BTIG Research Buy
2024-06-04 Iniziato Craig Hallum Buy
2024-04-09 Iniziato Maxim Group Buy
2022-08-02 Ripresa Canaccord Genuity Buy
2022-06-15 Iniziato Cantor Fitzgerald Overweight
2021-09-08 Iniziato ROTH Capital Buy
2021-05-27 Iniziato Oppenheimer Outperform
2021-05-25 Iniziato H.C. Wainwright Buy
Mostra tutto

Rezolute Inc Borsa (RZLT) Ultime notizie

pulisher
Dec 24, 2025

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The National Law Review

Dec 24, 2025
pulisher
Dec 24, 2025

ATTENTION RZLT Shareholders: Lost Money on Rezolute, Inc.? Contact Levi & Korsinsky About Investigation - ACCESS Newswire

Dec 24, 2025
pulisher
Dec 24, 2025

Jefferies’ Bullish Price Target Boosts Rezolute Amid Congenital Hyperinsulinism Data Anticipation - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

RZLT Stock Surge: Buy or Let Go? - StocksToTrade

Dec 24, 2025
pulisher
Dec 24, 2025

Jefferies Raises Rezolute Target to Spur Stock Optimism - timothysykes.com

Dec 24, 2025
pulisher
Dec 24, 2025

Investors Purchase Large Volume of Rezolute Put Options (NASDAQ:RZLT) - MarketBeat

Dec 24, 2025
pulisher
Dec 24, 2025

Rezolute, Inc. (RZLT) Stock News and Forecasts on Dec. 24, 2025: Phase 3 sunRIZE Miss, Analyst Target Cuts, and What Comes Next - ts2.tech

Dec 24, 2025
pulisher
Dec 23, 2025

Ongoing Rezolute, Inc. (RZLT) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire

Dec 23, 2025
pulisher
Dec 23, 2025

RZLT ALERT: Ongoing Investigation Into Rezolute, Inc.Contact Levi & Korsinsky - ACCESS Newswire

Dec 23, 2025
pulisher
Dec 23, 2025

INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - The Malaysian Reserve

Dec 23, 2025
pulisher
Dec 23, 2025

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - PR Newswire

Dec 23, 2025
pulisher
Dec 22, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 22, 2025
pulisher
Dec 21, 2025

Levi & Korsinsky Launches Fraud Investigation on Behalf of Rezolute, Inc. (RZLT) Shareholders - ACCESS Newswire

Dec 21, 2025
pulisher
Dec 21, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - 巴士的報

Dec 21, 2025
pulisher
Dec 21, 2025

Rezolute shares in focus after RA Capital discloses 9.9% stake - MSN

Dec 21, 2025
pulisher
Dec 20, 2025

Can Rezolute Inc. stock deliver surprise earnings beat2025 Price Action Summary & Advanced Swing Trade Entry Alerts - Улправда

Dec 20, 2025
pulisher
Dec 20, 2025

How geopolitical tensions affect Rezolute Inc. stockJuly 2025 Retail & Low Drawdown Momentum Ideas - ulpravda.ru

Dec 20, 2025
pulisher
Dec 19, 2025

Is Rezolute Inc. (6HV1) stock included in top ETFs2025 Volatility Report & Growth Oriented Trading Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

RZLT ALERT: Levi & Korsinsky Investigates Rezolute, Inc. on Behalf of Shareholders Who Lost Money - ACCESS Newswire

Dec 19, 2025
pulisher
Dec 19, 2025

REZOLUTE INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RZLT - FinancialContent

Dec 19, 2025
pulisher
Dec 19, 2025

Rezolute (RZLT) Misses Key CHI Endpoints: Does Ersodetug’s TIH Pivot Rewrite The Drug’s Story? - simplywall.st

Dec 19, 2025
pulisher
Dec 19, 2025

Is Rezolute Inc. stock a buy in volatile markets2025 Bull vs Bear & Low Drawdown Investment Ideas - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Will Rezolute Inc. stock outperform value stocks2025 Volume Leaders & AI Powered Market Trend Analysis - Bölüm Sonu Canavarı

Dec 19, 2025
pulisher
Dec 19, 2025

RA Capital Acquires 9.9% Stake in Rezolute (RZLT) - GuruFocus

Dec 19, 2025
pulisher
Dec 19, 2025

Will Rezolute Inc. (6HV1) stock benefit from infrastructure billJuly 2025 Price Swings & Technical Entry and Exit Tips - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Does Rezolute Inc. stock trade at a discount to peersJuly 2025 Action & Growth Oriented Trade Recommendations - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Is Rezolute Inc. (6HV1) stock expanding market penetrationGDP Growth & Technical Pattern Based Signals - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Why analysts upgrade Rezolute Inc. stock2025 Buyback Activity & Proven Capital Preservation Methods - DonanımHaber

Dec 19, 2025
pulisher
Dec 19, 2025

Is Rezolute Inc. stock positioned well for digital economy2025 Top Decliners & Risk Controlled Daily Trade Plans - Улправда

Dec 19, 2025
pulisher
Dec 19, 2025

Travel Stocks: How Rezolute Inc. (6HV1) stock trades after rate cutsCEO Change & Expert Curated Trade Setup Alerts - Улправда

Dec 19, 2025
pulisher
Dec 18, 2025

Shareholders Alert: Investigation Into Rezolute, Inc. (RZLT)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Dec 18, 2025
pulisher
Dec 18, 2025

Rezolute: Phase 3 sunRIZE Data For Ersodetug Warrants Downgrade To Sell Rating (RZLT) - Seeking Alpha

Dec 18, 2025
pulisher
Dec 18, 2025

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Fail - GuruFocus

Dec 18, 2025
pulisher
Dec 18, 2025

Insider Spends US$80k Buying More Shares In Rezolute - simplywall.st

Dec 18, 2025
pulisher
Dec 18, 2025

Chief Financial Officer of Rezolute Daron Evans Buys 21% More Shares - Yahoo Finance

Dec 18, 2025
pulisher
Dec 18, 2025

RZLT Stock Plummets 79% Month to Date: Here's What You Need to Know - The Globe and Mail

Dec 18, 2025
pulisher
Dec 17, 2025

Levi & Korsinsky Investigates Possible Securities Fraud by Rezolute, Inc. (RZLT) - ACCESS Newswire

Dec 17, 2025
pulisher
Dec 17, 2025

Top Executive Makes Bold Move in Rezolute Stock! - TipRanks

Dec 17, 2025
pulisher
Dec 17, 2025

Insider Buying: Wladimir Hogenhuis Acquires Additional Shares of Rezolute Inc (RZLT) - GuruFocus

Dec 17, 2025
pulisher
Dec 17, 2025

RZLT: Rezolute, Inc. Investigated for Securities Fraud; - GlobeNewswire

Dec 17, 2025
pulisher
Dec 17, 2025

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus

Dec 17, 2025
pulisher
Dec 17, 2025

SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute - PR Newswire

Dec 17, 2025
pulisher
Dec 16, 2025

Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares - Investing.com Nigeria

Dec 16, 2025
pulisher
Dec 16, 2025

Rezolute, Inc. (RZLT) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire

Dec 16, 2025
pulisher
Dec 16, 2025

Rezolute, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Losses Through The Firm's Investigation - ACCESS Newswire

Dec 16, 2025
pulisher
Dec 16, 2025

Rezolute, Inc. (RZLT) Shares Tank 90% Amid Lead Asset Trial Failure -- Hagens Berman Investigating - GlobeNewswire Inc.

Dec 16, 2025
pulisher
Dec 16, 2025

Elam Nevan C, Rezolute CEO, buys $50k in RZLT shares By Investing.com - Investing.com South Africa

Dec 16, 2025
pulisher
Dec 16, 2025

Lost Money on Rezolute, Inc. (RZLT)? Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire

Dec 16, 2025
pulisher
Dec 16, 2025

Did You Suffer Losses in Rezolute, Inc. (RZLT)? Contact Levi & Korsinsky About Securities Fraud Claims - ACCESS Newswire

Dec 16, 2025
pulisher
Dec 15, 2025

Entry Recap: Will Rezolute Inc stock outperform value stocksInflation Watch & AI Enhanced Trading Signals - moha.gov.vn

Dec 15, 2025
pulisher
Dec 15, 2025

Rezolute CFO Evans buys shares worth $79,577 By Investing.com - Investing.com Canada

Dec 15, 2025

Rezolute Inc Azioni (RZLT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Rezolute Inc Azioni (RZLT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
ROBERTS BRIAN KENNETH
Chief Medical Officer
Dec 16 '25
Buy
1.70
28,000
47,600
308,352
Evans Daron
CFO
Dec 15 '25
Buy
1.77
40,000
70,640
415,900
Evans Daron
CFO
Dec 15 '25
Buy
1.79
5,000
8,938
7,000
Elam Nevan C
CEO
Dec 15 '25
Buy
1.59
32,000
50,880
641,119
Karnawat Sunil Ratilal
Chief Commercial Officer
Dec 15 '25
Buy
1.62
12,100
19,599
71,542
ROBERTS BRIAN KENNETH
Chief Medical Officer
Jun 25 '25
Buy
4.38
2,500
10,939
15,500
Evans Daron
CFO
Jun 24 '25
Buy
4.05
5,000
20,250
268,900
Kim Young-Jin
Director
Jun 13 '25
Buy
3.25
1,230,769
3,999,999
8,423,386
KREHER NERISSA
Director
Jun 13 '25
Buy
3.25
3,076
9,997
37,576
Hogenhuis Wladimir
Director
Mar 31 '25
Buy
2.92
6,758
19,733
84,025
$39.25
price down icon 0.36%
$100.44
price down icon 0.47%
$33.72
price up icon 0.21%
$95.03
price up icon 0.95%
biotechnology ONC
$311.73
price down icon 0.19%
$177.42
price up icon 0.37%
Capitalizzazione:     |  Volume (24 ore):